期刊文献+

EIF4E基因下调对胃癌细胞的侵袭转移能力的影响及机制研究 被引量:1

Downregulation of EIF4E inhibits the metastasis of gastric cancer cell in vitro
在线阅读 下载PDF
导出
摘要 目的:探讨特异性下调真核起始因子EIF4E对胃癌细胞侵袭转移能力的影响及可能的作用机制。方法:采用siRNA技术下调EIF4E的表达,Western blot检测转染前后EIF4E和MMP9蛋白质表达,通过Traswell小室实验检测转染前后侵袭迁移能力的差异。结果:Western blot证实,与阴性对照相比,转染EIF4E siRNA组细胞EIF4E表达明显下调,同时与阴性对照相比,转染EIF4E siRNA组细胞MMP9蛋白表达同样明显下调,Traswell小室实验证实,下调EIF4E后,MKN28细胞的体外侵袭迁移能力显著降低。结论:在胃癌MKN28细胞中存在EIF4E基因对MMP9的调控作用,EIF4E基因可能通过调控MMP9的表达参与胃癌的侵袭迁移行为,EIF4E有望成为肿瘤基因治疗的新靶点。 Objective:To investigate the invasive and metastatic potential of EIF4E gene silencing by small inte-ring RNA on the human gastric cancer cell cell line MKN28. Methods:Using Lipofectamine 2000,EIF4E siRNA was transfected into MKN28 cells in vitro( siRNA transfect group). Negative control was established. Western blot was used to examine the difference of EIF4E and MMP9 expression in protein expression;Transwell assays were performed to identify the differences and changes of invasive and metastatic ability in gastric cancer cell line MKN28. Results:The expression levels of EIF4E and MMP9 protein expression in siRNA transfected MKN28 cells were lower than the matched negative control cells. The invasive and metastatic potentials of siRNA transfected MKN28 cells were signifi-cantly decreased. Conclusion:Using siRNA to down - regulate the expression of EIF4E can inhibit the invasion and metastasis ability of gastric cancer. EIF4E gene may be a potentially valuable therapeutic target in the treatment of gastric cancer.
出处 《现代肿瘤医学》 CAS 2015年第19期2709-2712,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81272516 81090273)
关键词 胃癌 侵袭 转移 EIF4E gastric cancer EIF4E invasion metastasis
  • 相关文献

参考文献13

  • 1De Benedetti A,Graff JR. EIF4E expression and its role in malig- nancies and metastases [ J ]. Oncogenc, 2004, 23 ( 18 ) : 3189 - 3199.
  • 2Graft J R, Konicek BW. Eif4E activation is commonly elevated in advanced human prostate canee~ and significantly related to re- duced patient survival [ J ] Cancer Res,2009,69 ( 9 ) :3866 - 3873.
  • 3Hu A, Sun M, Yan D, et al. Clinical significance of mTOR and elF4E expression in invasive ductal carcinonm[ J ]. Tumori, 2014, 100(5 ) :541 -546.
  • 4Gr',fff JR,Zimmer SG. Tnmslational control and metastalic progres- sion :enhanced activity of the mRNA cap - binding protein elF -4E selectively enhances translation of metastasis - related mRNAs[ J ]. Clin Exp Metastasis,2003,20 ( 3 ) 265 - 273.
  • 5McClusky DR,Chu Q,Yu tt,et al. A prospective trial on initiation factor 4E (elFdE) overexpression and cancer rccurrencc in node - positive breast cancer[ J ]. Ann Surg,2005,242 (4) :584 - 590.
  • 6Zhou S, Wang GP, Liu C, et al. Eukaryotic initiation faclor 4E(elF4E) and angiogenesis: prognostic markers for breast cancer [ J]. BMC Cancer,2006,6:23l.
  • 7刘月平,温文娟,王续,杨会钗,王小玲.eIF4E在食管鳞状细胞癌中表达及其与预后关系的研究[J].现代肿瘤医学,2014,22(2):317-320. 被引量:3
  • 8张国强,潘薇,赵亮,庞达.eIF-4E腺病毒载体构建及对乳腺癌MCF-7细胞转移能力的影响[J].中国生物工程杂志,2008,28(3):8-12. 被引量:2
  • 9Yang SX, Hewitt SM, Steinberg SM, et al. Expression levels ofeIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi- tumor tissue microarray [ J ]. On- col Rep,2007,17 ( 2 ) :281 - 287.
  • 10Martin ME, P6rez MI, Redondo C, et al. 4E binding protein 1 ex- pression is inversely correlated to the progression of gastrointesti- nal cancers [ J ]. Int J Biochem Cell Biol, 2000,32 ( 6 ) : 633 - 642.

二级参考文献36

  • 1黄红艳,孙强,李庆霞,刘家云,王凯,鲍炜,贾林涛,王成济,杨安钢.针对uPA的siRNA对人乳腺癌细胞侵袭的抑制作用[J].中国生物工程杂志,2005,25(6):31-35. 被引量:1
  • 2熊碧芳,方向明,胡继军.91例胃癌患者真核细胞起始因子与血管内皮生长因子的表达及其临床意义[J].临床内科杂志,2005,22(11):743-745. 被引量:5
  • 3程联胜,查昭,席甲甲,江冰,刘兢,姚雪彪.慢病毒介导的RNA干涉对乳腺癌SKBR3细胞HER2受体的下调及生长抑制[J].中国生物工程杂志,2007,27(2):1-8. 被引量:7
  • 4Donohue JH,Stewart AK ,Menck HR, et al. The national cancer date base report on carcinoma of the gallbladder, 1989-1995 [J]. Cancer, 1998,83 ( 12 ) : 2618-2628.
  • 5Heller J, Schepke M, Neef M, et al. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension[J]. Hepatol, 2002,37 (6) : 767-772.
  • 6Egeblad M,Werb Z. New functions for the matrix metaloproteinase in cancer progression[J]. Nature Rev Cancer,2002,2(3) : 164-174.
  • 7Shirabe K, Shmada M, Kajiyama K, et al. Expression of matrix metaUoproteinase-9 in surgically resected intrahepatic cholangiocarcinoma[J]. Surgery, 1999,126 ( 5 ) : 842-846.
  • 8Yao J,Xiong S,Klos K,et al. Multiple signaling pathways involved in activation of matrix metalloproteinase (MMP-9) by heregulin betal in human breast cancer cells[J]. Oncogene, 2001,20: 8066-8069.
  • 9Kim TD, Song KS, Li G, et al. Activity and expression of urokinasetype plasminogen activator and matrix metaUoproteinases in human colorectal cancer[J]. BMC Cancer,2006,6:211.
  • 10Zheng H,Takahshi H,Murai Y,et al. Expressions of MMP-2,MMP-9 and VEGF are closely linked to growth,invasion,metastasis and angiogenesis of gastric careinoma[J]. Anticancer Res, 2006, 26(5A): 3579-3581.

共引文献7

同被引文献5

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部